Featured Research

from universities, journals, and other organizations

Sensitivity to bodily symptoms of anxiety may make a difference in treatment in heart patients, study suggests

Date:
October 27, 2010
Source:
Heart and Stroke Foundation of Canada
Summary:
Levels of anxiety sensitivity may be important in choosing medical treatment for patients with heart failure and atrial fibrillation, researchers report.

Levels of anxiety sensitivity may be important in choosing medical treatment for patients with heart failure and atrial fibrillation (AF), Montreal Heart Institute researchers told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

Heart and Stroke Foundation researcher and lead author Nancy Frasure-Smith, PhD explained that anxiety sensitivity is the degree to which a person is frightened by bodily sensations and symptoms, particularly those associated with anxiety.

"For most people, sweaty palms and an increasing heart rate are simply unpleasant symptoms that occur in stressful situations, for others these same symptoms are interpreted as a sign of impending doom," says Dr. Frasure-Smith. "People with high anxiety sensitivity tend to magnify the potential consequences of their anxiety symptoms, leading to an increase in anxiety and its symptoms in a spiralling increase of fear and worry."

While anxiety sensitivity is known to predict the occurrence of panic attacks in cardiac and non-cardiac patients, and is associated with greater symptom preoccupation and worse quality of life in patients with AF, it has not been previously studied as a predictor of cardiac outcomes.

These results are based on a sub-study from the Atrial Fibrillation and Congestive Heart Failure Trial (AF-CHF), a randomized trial of rhythm versus rate control treatment strategies whose results were presented at the Canadian Cardiovascular Congress in 2008. AF-CHF, which was funded by the Canadian Institutes of Health Research, was directed by Dr. Denis Roy, cardiologist at the Montreal Heart Institute (MHI) and vice-dean of the Universitι de Montrιal's faculty of medicine.

Prior to randomization 933 AF-CHF study participants completed a paper and pencil measure of anxiety sensitivity. They were then randomly placed in one of two treatment groups: a 'rhythm' group that was treated with anti-arrhythmic medication and cardioversion (an electric shock to convert an abnormal heart rhythm back to normal rhythm); and a 'rate' group that received medication to help keep people's heart rates within a certain range.

Participants were followed for an average of 37 months. Results showed that, as in the overall AF-CHF trial, the majority of patients had as good a prognosis with the rate control strategy as with the rhythm control approach. In contrast, patients with high anxiety sensitivity had significantly better outcomes if they were treated with the more complicated rhythm control strategy.

"Increased emotional responses to AF symptoms in people with high anxiety sensitivity may lead to increased levels of stress hormones making them more vulnerable to fatal arrhythmias and worsening heart failure," says Dr. Frasure-Smith, a researcher at the MHI, adjunct professor of psychiatry at University of Montreal and professor of psychiatry at McGill University.

"For AF-CHF patients with high anxiety sensitivity maintenance of normal sinus rhythm appears to be important."

AF is a common type of heart arrhythmia which affects approximately a quarter of a million Canadians, including up to forty percent of individuals with congestive heart failure.

During AF the upper chamber of the heart (the atria) beats irregularly and very rapidly. Patients may experience palpitations, shortness of breath or chest pain. While by itself AF is usually not fatal, it increases the chances of heart failure and stroke. When AF and heart failure occur together, there is an increased risk of fatal outcomes, so finding the best treatment for each patient is extremely important.

"While the study − a sub analysis of a larger trial -- is not definitive in itself, it does raise interesting questions," says Heart and Stroke Foundation spokesperson Dr. Beth Abramson. We tend to underestimate the power of the mind in patients on powerful heart medications. Mental well being however is an important aspect of care for all heart patients."


Story Source:

The above story is based on materials provided by Heart and Stroke Foundation of Canada. Note: Materials may be edited for content and length.


Cite This Page:

Heart and Stroke Foundation of Canada. "Sensitivity to bodily symptoms of anxiety may make a difference in treatment in heart patients, study suggests." ScienceDaily. ScienceDaily, 27 October 2010. <www.sciencedaily.com/releases/2010/10/101025005844.htm>.
Heart and Stroke Foundation of Canada. (2010, October 27). Sensitivity to bodily symptoms of anxiety may make a difference in treatment in heart patients, study suggests. ScienceDaily. Retrieved July 26, 2014 from www.sciencedaily.com/releases/2010/10/101025005844.htm
Heart and Stroke Foundation of Canada. "Sensitivity to bodily symptoms of anxiety may make a difference in treatment in heart patients, study suggests." ScienceDaily. www.sciencedaily.com/releases/2010/10/101025005844.htm (accessed July 26, 2014).

Share This




More Health & Medicine News

Saturday, July 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) — A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) — The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) — The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) — Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins